Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
38.77
-0.54 (-1.37%)
At close: Dec 5, 2025, 4:00 PM EST
38.51
-0.26 (-0.67%)
After-hours: Dec 5, 2025, 7:58 PM EST
Cogent Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5,898 | 862 | 506 | 808 | 342 | 350 | |
| Market Cap Growth | 493.93% | 70.14% | -37.32% | 136.30% | -2.42% | - | |
| Enterprise Value | 5,568 | 644 | 273 | 605 | 228 | 365 | |
| Last Close Price | 38.77 | 7.80 | 5.88 | 11.56 | 8.58 | 11.23 | |
| PS Ratio | - | - | - | - | - | 44.52 | |
| PB Ratio | 27.88 | 3.36 | 1.96 | 3.16 | 1.60 | 1.49 | |
| P/TBV Ratio | 30.32 | 5.91 | 2.56 | 4.26 | 2.66 | 2.83 | |
| EV/Sales Ratio | - | - | - | - | - | 46.36 | |
| Debt / Equity Ratio | 0.20 | 0.07 | 0.07 | 0.08 | 0.02 | 0.02 | |
| Asset Turnover | - | - | - | - | - | 0.05 | |
| Quick Ratio | 6.28 | 5.15 | 6.96 | 9.66 | 12.86 | 18.50 | |
| Current Ratio | 6.38 | 5.32 | 7.09 | 9.87 | 13.04 | 18.70 | |
| Return on Equity (ROE) | -95.40% | -99.54% | -74.94% | -59.69% | -32.20% | -56.16% | |
| Return on Assets (ROA) | -47.47% | -53.78% | -42.35% | -34.68% | -19.55% | -14.69% | |
| Return on Capital (ROIC) | -55.28% | -62.67% | -47.13% | -37.51% | -20.66% | -15.89% | |
| Return on Capital Employed (ROCE) | -84.60% | -101.40% | -75.60% | -54.00% | -35.10% | -14.80% | |
| Earnings Yield | -4.99% | -29.70% | -38.00% | -17.36% | -21.14% | -21.35% | |
| FCF Yield | -4.18% | -24.18% | -30.89% | -15.53% | -17.69% | -10.23% | |
| Buyback Yield / Dilution | -21.79% | -30.36% | -35.54% | -51.89% | -249.52% | -45.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.